Related Experiment Video

Updated: Jul 5, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K

Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease

Yi-Ming Li1, Hong-Wei He1, Na Zhang1

  • 1NHC Key Laboratory of Biotechnology for Microbial Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.

Current Drug Targets
|January 12, 2024
PubMed

Insights

Protein phosphatases are crucial in chronic liver disease. Understanding their role aids in developing new drugs to treat this widespread condition.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Hepatology

Background:

  • Chronic liver disease affects millions globally, posing significant health risks.
  • Protein phosphorylation is vital for cell signaling; phosphatases regulate this process.
  • Dysregulation of phosphatases is implicated in the progression of liver diseases.

Purpose of the Study:

  • To review the critical functions of protein phosphatases in chronic liver disease.
  • To highlight the therapeutic potential of targeting protein phosphatases for liver disease treatment.

Main Methods:

  • Literature review of studies on protein phosphatases and liver disease.
  • Analysis of the role of specific phosphatases in liver pathogenesis.
  • Examination of current and potential drug development strategies targeting phosphatases.

Main Results:

  • Protein phosphatases play multifaceted roles in liver cell signaling and homeostasis.
  • Alterations in phosphatase activity are linked to various chronic liver conditions.
  • Targeting specific phosphatases shows promise for novel therapeutic interventions.

Conclusions:

  • Protein phosphatases are key players in the pathogenesis of chronic liver disease.
  • Further research into phosphatase-targeted therapies could lead to effective treatments.
  • Developing drugs targeting protein phosphatases is a promising avenue for managing liver disease.
Keywords:
Chronic liver diseasedrug discovery.hepatocellular carcinomaliver fibrosisnon-alcoholic fatty liver diseaseprotein phosphatasestarget identification

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

391
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

15.9K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
167
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
92
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K